Novel 3-galloylamido-N′-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 10, 2007, Pages 2935-2938

  Li, Qianbin ^a   Fang, Hao ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Aminopeptidase N; Conformational constraint; Matrix metalloproteinase; Peptidomimetics

Indexed keywords

ANTINEOPLASTIC AGENT; BESTATIN; GELATINASE A; METALLOPROTEINASE INHIBITOR; MICROSOMAL AMINOPEPTIDASE;

ARTICLE; BIOLOGICAL ACTIVITY; CONFORMATIONAL TRANSITION; DRUG ACTIVITY; DRUG DESIGN; DRUG INHIBITION; DRUG POTENCY; DRUG SYNTHESIS; IC 50; PEPTIDOMICS; STRUCTURE ACTIVITY RELATION;

ACETAMIDES; ANTIGENS, CD13; ENZYME INHIBITORS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34247372694     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.12.095     Document Type: Article

References (33)

1. Look A.T., Ashmun R.A., Shapiro L.H., Stephen C., and Peiper S.C. J. Clin. Invest. 83 (1989) 1299
2. Antczak C., De Meester I., and Bauvois B. BioEssays 23 (2001) 251
3. Taylor A. FASEB J. 7 (1993) 290
4. Maroux S., Louvard D., and Barrati H. Biochim. Biophys. Acta 321 (1973) 282
5. Dixon J., Kaklamanis L., Turley H., Hickson I.D., Leek R.D., Harris A.L., and Gatter K.C. J. Clin. Pathol. 47 (1994) 43
6. Delmas B., Gelfi J., L'Haridon R., SjöströmNorén H., and Laude H. Nature 357 (1992) 417
7. Yeager C.L., Ashmun R.A., Williams R.K., Cardellichio C.B., Shapiro L.H., Thomas Look A., and Holmes K.V. Nature 357 (1992) 420
8. Nakanishi K., Yaoi K., Nagino Y., Hara H., Kitami M., Atsumi S., Miura N., and Sato R. FEBS Lett. 519 (2002) 215
9. Irazusta J., Valdivia A., Fernandez D., Agirregoitia E., Ochoa C., and Casis L. J. Androl. 25 (2004) 733
10. Shipp M.A., and Look A.T. Blood 82 (1993) 1052
11. Kanayama N., Kajiwara Y., Goto J., el Maradny E., Maehara K., Andou K., and Terao T. J. Leukoc. Biol. 57 (1995) 129
12. Mitsui T., Nomura S., Itakura A., and Mizutani S. Biol. Pharm. Bull. 27 (2004) 768
13. Larsen S.L., Pedersen L.O., Buus S., and Stryhn A. J. Exp. Med. 184 (1996) 183
14. Hattori A., and Tsujimoto M. Biol. Pharm. Bull. 27 (2004) 777
15. Pulido-Cejudo G., Conway B., Proulx P., Brown R., and Izaguirre C.A. Antiviral Res. 36 (1997) 167
16. Saiki I., Fujii H., Yoneda J., Abe F., Nakajima M., Tsuruo T., and Azuma I. Int. J. Cancer 54 (1993) 137
17. Menrad A., Speicher D., Wacker J., and Herlyn M. Cancer Res. 53 (1993) 1450
18. O'Connell P.J., Gerkis V., and d'Apice A.J. J. Biol. Chem. 266 (1991) 4593
19. Fujii H., Nakajima M., Aoyagi T., and Tsuruo T. Biol. Pharm. Bull. 19 (1996) 6
20. Sato Y. Biol. Pharm. Bull. 772 (2004) 776
21. Xu W., and Li Q. Curr. Med. Chem.-Anti Cancer Agents 5 (2005) 281
22. Skiles J.W., Gonnella N.C., and Jeng A.Y. Curr. Med. Chem. 8 (2001) 425
23. Ramnath N., and Creaven P.J. Curr. Oncol. Rep. 6 (2004) 96
24. Sridhar S.S., and Shepherd F.A. Lung Cancer 42 (2003) 81
25. Kha A.R., Parrish J.C., Fraser M.E., Smith W.W., Bartlett P.A., and James M.N. Biochemistry 37 (1998) 16839
26. Dinsmore C.J., and Bell I.M. Curr. Top. Med. Chem. 3 (2003) 1075
27. Yeung K.S., Meanwell N.A., Qiu Z., Hernandez D., Zhang S., McPhee F., Weinheimer S., Clark J.M., and Janc J.W. J. Comput. Chem. 25 (2004) 1133
28. Wang J.L., and Xu W.F. J. Chem. Res. Synop. 12 (2003) 789
29. Pellegrina C.D., Padovani G., Mainente F., Zoccatelli G., Bissoli G., Mosconi S., Veneri G., Peruffo A., Andrighetto G., Rizzi C., and Chignola R. Cancer Lett. 226 (2005) 17
30. Ohno T., Inoue M., and Ogihara Y. Anticancer Res. 21 (2001) 3875
31. +; mp 98.7-100.6 °C.
32. 50 values against APN were determined as previously described using l-Leu-p-nitroanilide as substrate and microsomal aminopeptidase from Porcine Kidney Microsomes (Sigma) as the enzyme in 50 mM PBS, pH 7.2, at 37 °C
33. Vijaykumar M.B., Bonnie J.S., Richard R.R., Paul J.K., Howard G.W., Mahesh M., Jon R.C., and Srinivasa K.R. Matrix Biol. 19 (2000) 26 Gelatinase (MMP-2) and TNBS were purchased from Sigma, and the substance was synthesized as described by Vijaykumar et al. The gelatinase, substance, and inhibitor were dissolved in sodium borate (pH 8.5, 50 mmol/L) and incubated for 30 min at 37 °C, and then 0.03% TNBS was added and incubated for another 20 min, the resulting solution was detected under 450 nm wavelength to gain absorption.